Piedmont Capital Management (Montana)’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Piedmont Capital Management (Montana)'s JNJ Position: Q2 2026 in Review
Piedmont Capital Management (Montana) reduced its Johnson & Johnson (JNJ) stake by 4% in Q2 2026, selling an estimated $51.5K and leaving 5,358 shares worth $1.36M. The position accounts for 0.69% of the portfolio, ranked #21.
Piedmont Capital Management (Montana) first reported a position in JNJ in Q4 2020 and has held it in 21 quarters since. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Piedmont Capital Management (Montana) held 5,358 shares of Johnson & Johnson worth $1.36M as of Q2 2026.
- Piedmont Capital Management (Montana) sold 221 Johnson & Johnson shares in Q2 2026, an estimated $51.5K.
- Johnson & Johnson made up 0.69% of Piedmont Capital Management (Montana)'s portfolio in Q2 2026, its #21 holding.
- Piedmont Capital Management (Montana) first reported a position in Johnson & Johnson in Q4 2020 and has held it in 21 quarters since.
- 4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Piedmont Capital Management (Montana)'s 13F filing for Q2 2026, filed 13 Aug 2026.